Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-021501-20-IT
EUCTR2010-021501-20-IT
Active, not recruiting
Not Applicable

study for evaluation of 18F-choline PET/CT efficacy in patients with prostate carcinoma. - ND

ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED0 sitesJuly 14, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 14, 2010
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Male

Investigators

Sponsor
ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED

Eligibility Criteria

Inclusion Criteria

  • •\- Histologically proven prostate carcinoma
  • •\- PSA rising serum levels
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •\- Histologically proven prostate carcinoma

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Prospective comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the initial work-up of Multiple MyelomaMultiple myelomaMedDRA version: 20.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2018-003926-10-FRCHU de Bordeaux30
Active, not recruiting
Not Applicable
Evaluation of [18F]Fluorocholine PET/CT imaging for staging and restaging of prostate cancer - 18F-FCHPATIENTS AFFECTED BY PROSTATIC CANCERMedDRA version: 9.1Level: PTClassification code 10036222
EUCTR2009-016686-28-ITAZIENDA OSPEDALIERA DI PARMA
Completed
Phase 3
The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate CancerProstate Cancer
NCT02840552Sir Mortimer B. Davis - Jewish General Hospital60
Active, not recruiting
Not Applicable
Role of Pet with Choline in prostate cancer patientsprostate cancer patientsMedDRA version: 14.1Level: PTClassification code 10036911Term: Prostate cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]
EUCTR2011-004951-38-ITAZIENDA USL DI FORLI'
Completed
Not Applicable
Diagnostic Value of 18F-Choline PET/CT in Patients With a Thyroid Nodule With an Indeterminate Cytology: Pilot StudyThyroid Gland
NCT02784223Centre Francois Baclesse107